MDxHealth S.A. (MDXH) Stock Analysis
NASDAQHealthcareMedical - Diagnostics & Research
What MDxHealth S.A. does
MDxHealth SA is a commercial-stage precision diagnostics firm delivering specialized urologic solutions across the globe. Its international footprint includes the United States, various European nations such as the Netherlands, Belgium, Spain, Poland, Italy, and the wider European Union. The company's innovative genomic testing portfolio for prostate cancer comprises SelectMDx, a non-invasive urine test, and ConfirmMDx, an epigenetic diagnostic tool. These advanced offerings enable medical professionals to precisely identify clinically significant prostate cancer, thereby minimizing reliance on invasive procedures and their associated risks. Established in 2003, with its headquarters in Herstal, Belgium, the entity was formerly known as OncoMethylome Sciences SA until its renaming to MDxHealth SA in October 2010.
Key metrics
ETFs linked to MDXH
Broad-market and Healthcare sector ETFs an investor holding MDxHealth S.A. is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how MDXH fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze MDXH in PortView →Similar companies
Frequently asked questions
- What is the ticker symbol for MDxHealth S.A.?
- MDxHealth S.A. trades under the ticker MDXH on NASDAQ.
- Which exchange is MDXH listed on?
- MDXH is listed on NASDAQ.
- What sector does MDxHealth S.A. operate in?
- MDxHealth S.A. is classified in the Healthcare sector (Medical - Diagnostics & Research industry).
- How can PortView help analyze MDXH in a portfolio?
- PortView shows MDXH's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.